Gene-body hypermethylation controlled cryptic promoter and miR26A1-dependent EZH2 regulation of TET1 gene activity in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Gene-body hypermethylation controlled cryptic promoter and miR26A1-dependent EZH2 regulation of TET1 gene activity in chronic lymphocytic leukemia

Published:2017-09-06 Issue:44 Volume:8 Page:77595-77608
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kopparapu Pradeep Kumar¹,Abdelrazak Morsy Mohammad Hamdy¹,Kanduri Chandrasekhar²,Kanduri Meena¹

Affiliation:

1. Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden

2. Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review;Advances in Hematology;2024-01

2. Seven non-differentially expressed ‘dark biomarkers’ show transcriptional dysregulation in chronic lymphocytic leukemia;Personalized Medicine;2023-03

3. Regulation of non-coding RNA promoters;Bidirectional Gene Promoters;2023

4. Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression;Frontiers in Pharmacology;2022-10-05

5. Long non-coding RNA CRNDE suppressing cell proliferation is regulated by DNA methylation in chronic lymphocytic leukemia;Leukemia Research;2021-06